Federated Hermes’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Federated Hermes’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,638	Closed	-$2.29K	–	2252
2023 Q2	$2.29K	Hold	2,638	–	–	﹤0.01%	1985
2023 Q1	$1.84K	Sell	2,638 -136	-5%	-$110	﹤0.01%	2008
2022 Q4	$2.27K	Buy	2,774 +1,622	+141%	+$1.6K	﹤0.01%	1995
2022 Q3	$1K	Buy	+1,152	New	+$1.84K	﹤0.01%	2113
2022 Q1	–	Sell	-3	Closed	-$1K	–	2365
2021 Q4	$1K	Buy	+3	New	+$19	﹤0.01%	2180
2021 Q1	–	Sell	-446	Closed	-$4K	–	2382
2020 Q4	$4K	Buy	+446	New	+$3.88K	﹤0.01%	2074
2019 Q4	–	Sell	-734	Closed	-$1K	–	2333
2019 Q3	$1K	Sell	734 -828	-53%	-$1.81K	﹤0.01%	2151
2019 Q2	$4K	Buy	+1,562	New	+$6.22K	﹤0.01%	2028

Federated Hermes's SURF Position: Q3 2023 in Review

Federated Hermes sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 2,638 shares — an estimated $2.29K sold.

Federated Hermes first reported a position in SURF in Q2 2019 and held it in 8 quarters. The position peaked at $4K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Federated Hermes reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 2,638 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $2.29K.
Federated Hermes first reported a position in Surface Oncology, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Federated Hermes's Surface Oncology, Inc. Common Stock position peaked at $4K in Q4 2020.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.